155 related articles for article (PubMed ID: 33097858)
1. EAG1 enhances hepatocellular carcinoma proliferation by modulating SKP2 and metastasis through pseudopod formation.
Chen J; Xuan Z; Song W; Han W; Chen H; Du Y; Xie H; Zhao Y; Zheng S; Song P
Oncogene; 2021 Jan; 40(1):163-176. PubMed ID: 33097858
[TBL] [Abstract][Full Text] [Related]
2. Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC.
de Guadalupe Chávez-López M; Pérez-Carreón JI; Zuñiga-García V; Díaz-Chávez J; Herrera LA; Caro-Sánchez CH; Acuña-Macías I; Gariglio P; Hernández-Gallegos E; Chiliquinga AJ; Camacho J
Tumour Biol; 2015 Aug; 36(8):6149-58. PubMed ID: 25783527
[TBL] [Abstract][Full Text] [Related]
3. HANR promotes lymphangiogenesis of hepatocellular carcinoma via secreting miR-296 exosome and regulating EAG1/VEGFA signaling in HDLEC cells.
Shi Y; Yang X; Xue X; Sun D; Cai P; Song Q; Zhang B; Qin L
J Cell Biochem; 2019 Oct; 120(10):17699-17708. PubMed ID: 31127654
[TBL] [Abstract][Full Text] [Related]
4. The potassium channel KCa3.1 promotes cell proliferation by activating SKP2 and metastasis through the EMT pathway in hepatocellular carcinoma.
Du Y; Song W; Chen J; Chen H; Xuan Z; Zhao L; Chen J; Jin C; Zhou M; Tuo B; Zhao Y; Zheng S; Song P
Int J Cancer; 2019 Jul; 145(2):503-516. PubMed ID: 30628729
[TBL] [Abstract][Full Text] [Related]
5. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
[TBL] [Abstract][Full Text] [Related]
6. Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
Bernal-Ramos G; Hernández-Gallegos E; Vera E; Chávez-López MG; Zúñiga-García V; Sánchez-Pérez Y; Garrido E; Camacho J
Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):11-13. PubMed ID: 29307346
[TBL] [Abstract][Full Text] [Related]
7. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
8. Potassium channel ether à go-go1 is aberrantly expressed in human liposarcoma and promotes tumorigenesis.
Wu J; Zhong D; Wei Y; Wu X; Kang L; Ding Z
Biomed Res Int; 2014; 2014():345678. PubMed ID: 25136578
[TBL] [Abstract][Full Text] [Related]
9. Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
Chávez-López MG; Zúñiga-García V; Castro-Magdonel BE; Vera E; Garrido E; Sánchez-Ramos J; Ponce-Castañeda MV; Cabrera-Muñoz ML; Escobar Y; Ortiz CS; Hernández-Gallegos E; Avalos-Fuentes A; Camacho J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31973216
[TBL] [Abstract][Full Text] [Related]
10. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation.
Wang H; Luo J; Tian X; Xu L; Zhai Z; Cheng M; Chen L; Luo S
Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):118994. PubMed ID: 33662413
[TBL] [Abstract][Full Text] [Related]
11. In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.
García-Quiroz J; García-Becerra R; Santos-Martínez N; Barrera D; Ordaz-Rosado D; Avila E; Halhali A; Villanueva O; Ibarra-Sánchez MJ; Esparza-López J; Gamboa-Domínguez A; Camacho J; Larrea F; Díaz L
BMC Cancer; 2014 Oct; 14():745. PubMed ID: 25280486
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol inhibits Ether-à go-go potassium channel expression and cell proliferation in human breast cancer cells.
García-Becerra R; Díaz L; Camacho J; Barrera D; Ordaz-Rosado D; Morales A; Ortiz CS; Avila E; Bargallo E; Arrecillas M; Halhali A; Larrea F
Exp Cell Res; 2010 Feb; 316(3):433-42. PubMed ID: 19932096
[TBL] [Abstract][Full Text] [Related]
13. Exportin-T promotes tumor proliferation and invasion in hepatocellular carcinoma.
Lin J; Hou Y; Huang S; Wang Z; Sun C; Wang Z; He X; Tam NL; Wu C; Wu L
Mol Carcinog; 2019 Feb; 58(2):293-304. PubMed ID: 30334580
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
Zhang JY; Weng MZ; Song FB; Xu YG; Liu Q; Wu JY; Qin J; Jin T; Xu JM
Int J Oncol; 2016 Apr; 48(4):1590-8. PubMed ID: 26892468
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression.
Wu J; Zhong D; Fu X; Liu Q; Kang L; Ding Z
Int J Mol Sci; 2014 Apr; 15(4):5570-81. PubMed ID: 24694542
[TBL] [Abstract][Full Text] [Related]
16. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
[TBL] [Abstract][Full Text] [Related]
17. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
[TBL] [Abstract][Full Text] [Related]
18. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
[TBL] [Abstract][Full Text] [Related]
19. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
20. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
[No Abstract] [Full Text] [Related]
[Next] [New Search]
